NDC 70518-4128-01 - Glipizide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4128
- Requested NDC
- 70518-4128-01
- Package NDCs from labels
- 70518-4128-0, 70518-4128-1, 70518-4128-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glipizide - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4128-0 | Glipizide | 30 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 30 | 4 | |
| 70518-4128-1 | Glipizide | 90 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-4128 | GLIPIZIDE (GLIPIZIDE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] | 1 | Current NDC, 2 package rows | 20240703_667dd68a-d3e7-4b50-bd0a-d17783a090d5.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Systane | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | Alcon Research Ltd | 14916d2c-a63d-491e-bd91-a61f300af38a | 2023-12-15 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane Lubricant | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 15bc06ec-f3dc-3180-ca1a-106769a770ea | 2023-12-15 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane ULTRA | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a5c1c194-3db5-4f18-9cd1-97f7f84c3cff | 2023-12-15 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 7eaa93ca-c843-4c89-921b-c76659410dce | 2023-12-14 | Warnings | 6DC9Q167V3 |
| GenTeal Tears Gel Drops | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 84388a75-9d11-48ce-bf5a-88f0580d2d03 | 2023-12-14 | Warnings | 6DC9Q167V3 B697894SGQ |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 5014a2d7-e0d3-4e84-9a3e-c90b398b8c6c | 2023-12-04 | Warnings, Adverse reactions | 315107 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 15308fc4-11e3-4cd5-8f04-ab8e3433cc7d | 2023-12-04 | Warnings, Adverse reactions | 315107 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 4982f018-c53c-48ec-a4e8-4834228bcf2c | 2023-11-24 | Warnings, Adverse reactions | 315107 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 08b01608-73c2-45e0-8de4-c6c401261152 | 2023-10-23 | Warnings, Adverse reactions | ANDA206928 315107 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 695c178f-77f0-451e-b718-72b65e495b7e | 2023-10-18 | Warnings, Adverse reactions | ANDA206928 314006 X7WDT95N5C |
| Glipizide | GLIPIZIDE | TruPharma LLC | 95ea4c96-84b9-4515-9494-a93d26820f70 | 2023-10-11 | Warnings, Adverse reactions | X7WDT95N5C |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 6DC9Q167V3 |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 6DC9Q167V3 B697894SGQ |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 6DC9Q167V3 B697894SGQ |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 6DC9Q167V3 5138Q19F1X |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 6DC9Q167V3 B697894SGQ |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 6DC9Q167V3 |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.